ClinConnect ClinConnect Logo
Search / Trial NCT06958081

tDCS and Musical Performance in Young Orchestra Musicians

Launched by CENTRO UNIVERSITÁRIO AUGUSTO MOTTA · Apr 27, 2025

Trial Information

Current as of July 27, 2025

Not yet recruiting

Keywords

T Dcs Transcranial Direct Current Stimulation Music Performance Motor Control Self Efficacy Anxiety

ClinConnect Summary

This clinical trial is exploring whether a technique called transcranial direct current stimulation (tDCS) can help young musicians perform better and feel less anxious while playing music. Specifically, the study will look at musicians aged 18 to 30 who have at least three years of experience playing in an orchestra. Participants will be divided into two groups: one will receive active tDCS, while the other will get a placebo treatment (sham stimulation) that doesn’t have any real effect. Researchers want to see if those who receive the active treatment perform better musically and feel more confident and less anxious about their performances.

Eligible participants should be healthy young musicians who are currently involved in an orchestra and do not have any history of neurological or psychiatric issues. During the trial, each musician will perform a piece of music before and after receiving stimulation and complete questionnaires about their anxiety and confidence in their musical abilities. It's important to note that the study is not yet recruiting participants, so there’s still time to consider if you or someone you know might be interested in joining.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Musicians aged 18 to 30 years.
  • Minimum of 3 years of orchestral performance experience.
  • Active participation in a stable orchestra or ensemble.
  • No history of neurological or psychiatric disorders.
  • Not currently using psychotropic medications or recreational drugs.
  • Willingness to participate in all study sessions.
  • Signed informed consent form.
  • Exclusion Criteria:
  • Presence of metallic implants in the head (e.g., cranial pins, aneurysm clips).
  • Presence of implanted electronic devices (e.g., pacemaker).
  • History of epilepsy or seizures.
  • Prior experience with transcranial direct current stimulation (tDCS).
  • Scalp dermatitis or lesions at the electrode placement sites.
  • Pregnancy.

About Centro Universitário Augusto Motta

Centro Universitário Augusto Motta (CEHAM) is a distinguished higher education institution in Brazil, dedicated to advancing medical research and clinical trials. With a strong emphasis on innovation and scientific excellence, CEHAM fosters an environment that encourages collaboration among health professionals, researchers, and students. The institution is committed to conducting rigorous clinical studies that contribute to the enhancement of healthcare practices and the development of new therapies. CEHAM’s multidisciplinary approach and adherence to ethical standards ensure that its clinical trials are conducted with the utmost integrity, aiming to improve patient outcomes and drive forward the frontiers of medical knowledge.

Locations

Rio De Janeiro, Rj, Brazil

Patients applied

0 patients applied

Trial Officials

Ricardo Galhardoni, Ph.D

Principal Investigator

Neuromodulação em Foco

Renato Santos de Almeida, Ph.D

Study Chair

Centro Universitário Augusto Motta

Débora Cristina Lima da Silva, Ph.D

Principal Investigator

Centro Universitário Augusto Motta

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported